Upload Avatar (500 x 500)
Jialing Liu
Medical School
Southern University of Science and Technology
Guangdong
Language: Chinese, English
Cancer
Metastasis
Molecular Biology
Melanoma
Circulating Tumor Cells
Biomarkers
Therapeutic Response
Cell Biology
Pathology
Clinical Pharmacology
Areas of Focus
- Molecular biology mechanisms of cancer metastasis using melanoma circulating tumor cells
Work Experience
- 2023-11 to present - Southern University of Science and Technology, Medical School, Research Assistant Professor
- 2022-11 to 2023-11 - Southern University of Science and Technology, Medical School, Senior Research Scholar
- 2020-10 to 2022-11 - Southern University of Science and Technology, Medical School, Postdoctoral Researcher
Academic Background & Achievements
- 2017-09 to 2020-06 PhD in Medicine: Guangzhou University of Chinese Medicine and Harvard Medical School
- Hosted 1 National Natural Science Foundation project and 1 Guangdong Provincial Natural Science Foundation project
Publications
- Integrin alpha-5 is regulated by miR-218-5p in endothelial progenitor cells, Jialing Liu et al., 2022
- Hyperoside Suppresses Renal Inflammation by Regulating Macrophage Polarization in Mice with Type 2 Diabetes Mellitus, Jialing Liu et al., 2021
- miR-218 Expressed in Endothelial Progenitor Cells Contributes to the Development and Repair of the Kidney Microvasculature, Jialing Liu et al., 2020
- Comment on 'Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab', Jialing Liu et al., 2020
- Circulating Tumor Cells (CTCs): A Unique Model of Cancer Metastases and Non-invasive Biomarkers of Therapeutic Response, Jialing Liu et al., 2021
Awards
- 2021: Shenzhen Overseas High-level Talent (Category C)
- 2018: Guangzhou University of Chinese Medicine International Exchange Program Scholarship for Study Abroad
